| 摘要 |
The present invention relates to methods of treating hematological malign ancies, including acute myeloid leukemia (AML), comprising the use of compou nds that inhibit the binding of the Smac protein to IAPs ("IAP inhibitor"). The present invention also relates to the use of IAP inhibitors for the prep aration of a medicament to treat hematological malignancies, including AML..
|
